Mona R Loutfy

Summary

Affiliation: Women's College Hospital
Country: Canada

Publications

  1. pmc Learning from Interviews with HIV-Discordant Couples (Male Positive, Female Negative): The Challenges and Successes
    Sandy N Tecimer
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Open AIDS J 5:37-43. 2011
  2. pmc HIV, gender, race, sexual orientation, and sex work: a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada
    Carmen H Logie
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Ontario, Canada
    PLoS Med 8:e1001124. 2011
  3. pmc Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada
    Yimeng Zhang
    Women and HIV Research Program, Women s College Research Institute, Women s College Hospital, Toronto, ON, Canada M5G 1N6
    ISRN Obstet Gynecol 2012:853503. 2012
  4. pmc Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study
    Angela Cescon
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    PLoS ONE 8:e83649. 2013
  5. pmc Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS
    Allison J Carter
    Simon Fraser University, Faculty of Health Sciences, Burnaby, British Columbia, Canada
    J Int AIDS Soc 16:17433. 2013
  6. pmc Caring for women living with HIV: gaps in the evidence
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Ontario, Canada
    J Int AIDS Soc 16:18509. 2013
  7. pmc A review of reproductive health research, guidelines and related gaps for women living with HIV
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, ON, Canada
    AIDS Care 25:657-66. 2013
  8. pmc Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
    Mona Rafik Loutfy
    Women s College Research Institute, Women s College Hospital, 790 Bay Street, Room 736, Toronto, Ontario M5G 2N8, Canada
    BMC Infect Dis 13:256. 2013
  9. pmc Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Canada
    PLoS ONE 8:e55747. 2013
  10. pmc Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada
    Mona R Loutfy
    Department of Medicine, Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    PLoS ONE 7:e48168. 2012

Collaborators

Detail Information

Publications58

  1. pmc Learning from Interviews with HIV-Discordant Couples (Male Positive, Female Negative): The Challenges and Successes
    Sandy N Tecimer
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Open AIDS J 5:37-43. 2011
    ....
  2. pmc HIV, gender, race, sexual orientation, and sex work: a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada
    Carmen H Logie
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Ontario, Canada
    PLoS Med 8:e1001124. 2011
    ..The study objective was to explore experiences of stigma and coping strategies among HIV-positive women in Ontario, Canada...
  3. pmc Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada
    Yimeng Zhang
    Women and HIV Research Program, Women s College Research Institute, Women s College Hospital, Toronto, ON, Canada M5G 1N6
    ISRN Obstet Gynecol 2012:853503. 2012
    ..Fertility service professionals need to be aware of the increasing demand for ART among WLWHIV...
  4. pmc Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study
    Angela Cescon
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, Canada
    PLoS ONE 8:e83649. 2013
    ..This study investigates gender differences by injection drug use (IDU) history in virologic responses to ART and mortality...
  5. pmc Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS
    Allison J Carter
    Simon Fraser University, Faculty of Health Sciences, Burnaby, British Columbia, Canada
    J Int AIDS Soc 16:17433. 2013
    ..The objective of this investigation was to explore the concept of women-specific HIV/AIDS services to identify and define what key elements underlie this approach to care...
  6. pmc Caring for women living with HIV: gaps in the evidence
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Ontario, Canada
    J Int AIDS Soc 16:18509. 2013
    ..Furthermore, there are clinical issues unique to women, including gynaecologic and breast diseases, menopause-related factors, contraception and other topics related to women's and sexual health...
  7. pmc A review of reproductive health research, guidelines and related gaps for women living with HIV
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, ON, Canada
    AIDS Care 25:657-66. 2013
    ..Answering these questions and countering these inequalities will help to ensure the reproductive health and child-bearing intentions of WLWH become an integral part of HIV medicine...
  8. pmc Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
    Mona Rafik Loutfy
    Women s College Research Institute, Women s College Hospital, 790 Bay Street, Room 736, Toronto, Ontario M5G 2N8, Canada
    BMC Infect Dis 13:256. 2013
    ....
  9. pmc Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, University of Toronto, Toronto, Canada
    PLoS ONE 8:e55747. 2013
    ....
  10. pmc Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada
    Mona R Loutfy
    Department of Medicine, Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    PLoS ONE 7:e48168. 2012
    ..Findings suggest differing approaches may be required to address HIV-related stigma based on gender and ethnicity; and such strategies should challenge racist and sexist stereotypes...
  11. doi request reprint Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy
    Mona R Loutfy
    Maple Leaf Medical Clinic, Toronto, Ontario, Canada
    HIV Clin Trials 12:323-32. 2011
    ..To evaluate polyalkylamide gel (PAIG) use in treating HIV-associated facial lipoatrophy (FLA) 4 years after its injection in an open-label, randomized controlled trial (RCT)...
  12. doi request reprint High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study
    Mr Loutfy
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario
    HIV Med 13:107-17. 2012
    ..There is speculation, but there are few data, on the high rates of unintended pregnancies in HIV-positive women. We investigated rates and correlates of unintended pregnancies among HIV-positive women of reproductive age...
  13. ncbi request reprint Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical setting
    M R Loutfy
    Department of Medicine, University of Toronto, Toronto, Ontario Maple Leaf Medical Clinical, Toronto, Ontario, Canada
    HIV Clin Trials 8:36-44. 2007
    ..To evaluate the effectiveness and safety of enfuvirtide-based therapy in treatment-experienced patients in a clinical setting...
  14. ncbi request reprint A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression
    Mona R Loutfy
    University of Toronto, Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 55:451-9. 2010
    ..To determine the long-term impact of immunologic discordance (viral load <50 copies/mL and CD4+ count <=200 cells/mm3) in antiretroviral-naive patients initiating combination antiretroviral therapy (cART)...
  15. pmc Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study
    Mona R Loutfy
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    PLoS ONE 4:e7925. 2009
    ..In order to clarify the demand, and aid with appropriate health services planning for this population, our study aims to assess the fertility desires and intentions of HIV-positive women of reproductive age living in Ontario, Canada...
  16. ncbi request reprint A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration
    M R Loutfy
    Department of Medicine, University of Toronto, Maple Leaf Medical Clinic, and Department of Family and Community Medicine, St Michael s Hospital, Toronto, Ontario, Canada
    HIV Med 8:427-32. 2007
    ..Tualatin, OR, USA) relative to standard needles...
  17. pmc Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
    Kenneth H Huang
    Research Institute of McGill University Health Center, Montreal, Quebec, Canada
    BMC Infect Dis 8:59. 2008
    ..The objective of this study was to determine the predictive value of pre-TI proliferative capacity and cell surface markers for CD4 count change in HIV-infected patients experiencing virologic failure before undergoing TI...
  18. ncbi request reprint Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids
    Sarah E Ward
    Toronto General Research Institute and University of Toronto, ON, Canada
    Antivir Ther 10:263-75. 2005
    ....
  19. doi request reprint Once daily dosing improves adherence to antiretroviral therapy
    Janet Raboud
    Division of Infectious Disease, University Health Network, Toronto, ON, Canada
    AIDS Behav 15:1397-409. 2011
    ..Other independent correlates of suboptimal adherence were younger age, lower positive social interaction and increased frequency of consuming > 6 alcoholic drinks on one occasion...
  20. doi request reprint Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy
    Darrell H S Tan
    Department of Medicine, University of Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 58:38-46. 2011
    ..Controversy about the relative performance of abacavir (ABC)/lamivudine (3TC) and tenofovir (TDF)/emtricitabine (FTC) in initial combination antiretroviral therapy (cART) exists...
  21. ncbi request reprint Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada
    Tony Antoniou
    Department of Family and Community Medicine, St Michael s Hospital, Toronto, Ontario, Canada
    J Int Assoc Provid AIDS Care 13:153-9. 2014
    ..To evaluate the trends in abacavir (ABC) prescription among antiretroviral (ARV) medication-naive individuals following the presentation of the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) cohort study...
  22. pmc Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study
    Janet Raboud
    Toronto General Research Institute, University Health Network, Room 13EN226, 200 Elizabeth St, Toronto, Ontario M5G 2C4, Canada
    BMC Med Res Methodol 13:31. 2013
    ..These dissimilarities may limit the generalizability of results of research studies. Quantification of the participation bias is essential for the interpretation of research findings...
  23. pmc Case series of fertility treatment in HIV-discordant couples (male positive, female negative): the Ontario experience
    Trent Newmeyer
    Brock University, St Catharines, Ontario, Canada
    PLoS ONE 6:e24853. 2011
    ..Access to sperm washing and fertility service is significantly limited for this population and is accompanied with a number of challenges...
  24. doi request reprint Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada
    Alexis K Palmer
    British Columbia Centre for Excellence in HIV AIDS, Vancouver, BC, Canada
    J Int Assoc Provid AIDS Care 13:56-62. 2014
    ..The high number of young adults in our cohort starting HAART late indicates important target populations for specialized services, increased testing, and linkages to care. ..
  25. pmc Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries
    Janet M Raboud
    Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
    BMC Infect Dis 10:40. 2010
    ....
  26. pmc Socio-economic- and sex-related disparities in rates of hospital admission among patients with HIV infection in Ontario: a population-based study
    Tony Antoniou
    Department of Family and Community Medicine at St Michael s Hospital and an Assistant Professor in the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Open Med 6:e146-54. 2012
    ..As such, population-based assessments of the utilization of inpatient services represent a necessary component of evaluating the quality of HIV-related care...
  27. doi request reprint Physician attitudes regarding pregnancy, fertility care, and assisted reproductive technologies for HIV-infected individuals and couples
    Mark H Yudin
    Department of Obstetrics and Gynecology, St Michael s Hospital, Toronto, Ontario, Canada
    HIV Clin Trials 13:357-71. 2012
    ..There is a paucity of data regarding physician attitudes with respect to reproduction in this population, but some evidence suggests that attitudes can influence the information, advice, and services they will provide...
  28. ncbi request reprint Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients
    Mona R Loutfy
    Maple Leaf Medical Clinic, 70 Carlton Street, Toronto, Ontario, Canada
    AIDS 21:1147-55. 2007
    ..To evaluate the safety and efficacy of polyalkylimide gel (PAIG) in the treatment of HIV-associated facial lipoatrophy...
  29. doi request reprint Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy
    Janet Raboud
    University Health Network, Toronto, Ontario, Canada
    HIV Clin Trials 11:340-50. 2010
    ..To determine the effects of gender and calendar year on time to and duration of virologic suppression among HIV-infected antiretroviral-naïve individuals initiating combination antiretroviral therapy (cART)...
  30. ncbi request reprint A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164)
    Sharon L Walmsley
    Department of Medicine, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 45:418-25. 2007
    ..The primary endpoint was the percentage of patients with a 3-month sustained HIV RNA level <50 copies/mL...
  31. doi request reprint Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases
    Denise Jaworsky
    Faculty of Medicine, University of Toronto, Toronto, ON, Canada
    Antivir Ther 15:677-80. 2010
    ..However, data on their safety and efficacy in preventing vertical transmission are limited...
  32. ncbi request reprint The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada
    V Logan Kennedy
    a Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    AIDS Care 26:777-84. 2014
    ..1; 95% CI 3.2-61.5), and having previously given birth (OR 11.2; 95% CI 5.1-24.4). The majority of women felt strongly that motherhood was important to them particularly among younger women, recent immigrants, and women who were mothers...
  33. doi request reprint Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada
    Nisha Andany
    Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    HIV Clin Trials 12:89-103. 2011
    ..This study assessed ethnicity and gender differences in prevalence, type, and severity of antiretroviral-associated lipodystrophy in HIV-positive individuals in Ontario...
  34. doi request reprint Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial
    Duncan Chege
    Department of Medicine, University of Toronto, Ontario, Canada
    AIDS 26:167-74. 2012
    ..However, despite completely suppressive HAART, it has been suggested that low-levels of viral replication may persist in the gut mucosa and elsewhere in individuals on long-term HAART...
  35. doi request reprint Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history
    Angela Cescon
    aBritish Columbia Centre for Excellence in HIV AIDS, Vancouver, British Columbia bUniversity Health Network, Toronto cUniversity of Toronto dOntario HIV Treatment Network, Toronto, Ontario eMcGill University, Montreal, Quebec fWomen s College Research Institute, Toronto gMaple Leaf Medical Clinic, Toronto, Ontario hClinique Médicale l Actuel, Montreal, Quebec iUniversity of British Columbia, Vancouver jSimon Fraser University, Burnaby, British Columbia kUniversity of Ottawa, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada The members of the CANOC Collaboration are listed in the Acknowledgements
    AIDS 28:121-7. 2014
    ..This study compares HIV treatment outcomes and survival between HIV-HCV coinfected individuals with and without IDU history...
  36. pmc Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy
    Victor Leung
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
    PLoS ONE 8:e77665. 2013
    ..We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI) and death...
  37. ncbi request reprint Correlates of HIV stigma in HIV-positive women
    Anne C Wagner
    Department of Psychology, Ryerson University, 105 Bond Street, Toronto, ON M5B 1Y3, Canada
    Arch Womens Ment Health 13:207-14. 2010
    ..Health care providers should be trained in the provision of sensitive and effective health care for women living with HIV, especially when providing reproductive health care...
  38. ncbi request reprint Severe acute respiratory syndrome: quantitative assessment from chest radiographs with clinical and prognostic correlation
    Enoch K Y Lai
    Department of Medical Imaging, North York General Hospital, 4001 Leslie St, Toronto, ON M2K 1E1, Canada
    AJR Am J Roentgenol 184:255-63. 2005
    ..This study examined findings of severe acute respiratory syndrome (SARS) on chest radiographs and presented a classification scheme using quantitative radiographic data supported by clinical parameters...
  39. ncbi request reprint Canadian HIV pregnancy planning guidelines
    Mona R Loutfy
    Canadian HIV Pregnancy Planning Guideline Development Team, Toronto, Ontario
    J Obstet Gynaecol Can 34:575-90. 2012
    ..These guidelines are evidence- and community-based and flexible, and they take into account diverse and intersecting local/population needs and the social determinants of health...
  40. doi request reprint The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
    Jeff E Powis
    Department of Medicine, University of Toronto, Ontario, Canada
    J Infect Dis 205:1534-8. 2012
    ....
  41. ncbi request reprint Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen
    Mona R Loutfy
    Department of Medicine, University of Toronto, Toronto, Canada
    HIV Clin Trials 8:259-68. 2007
    ....
  42. doi request reprint Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy
    Jeya T Nadarajah
    University Health Network, Toronto, Ontario, Canada
    Clin Infect Dis 55:1568-74. 2012
    ..The objective of this study was to determine the incidence rate of infectious complications associated with Bio-Alcamid facial filler in patients with HIV-related facial lipoatrophy (FLA)...
  43. ncbi request reprint HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis
    Janice Du Mont
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Sex Transm Dis 35:973-8. 2008
    ..This study examined the use of HIV postexposure prophylaxis (PEP) among sexually assaulted adolescent females...
  44. ncbi request reprint Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada
    Anita C Benoit
    a Department of Medicine, Women s College Research Institute, Women s College Hospital, Toronto, ON, Canada
    AIDS Care 26:694-701. 2014
    ..Approaches to manage psychological distress should address and make considerations for the lived experiences of women since they can act as potential barriers to improving psychological well-being...
  45. ncbi request reprint Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma
    Matthew C Cheung
    Department of Medicine, Division of Hematology Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
    Ann Hematol 86:631-8. 2007
    ..The majority prefer to use cART in combination with CHOP for ARL. The use and perceived benefit of rituximab may be influenced by interprovincial formulary differences and regional variation in guideline recommendations...
  46. ncbi request reprint Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome
    Stephen Chihrin
    University of Western Ontario, Faculty of Medicine, London, Ontario, Canada
    Expert Rev Anti Infect Ther 3:251-62. 2005
    ..This review summarizes treatment agents assessed during and after the 2003 severe acute respiratory syndrome outbreak, with the aim of guiding future decision makers should the virus return...
  47. doi request reprint HIV protease inhibitors in pregnancy : pharmacology and clinical use
    Nisha Andany
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    Drugs 73:229-47. 2013
    ..This paper reviews the use of protease inhibitors in pregnancy, focusing on pharmacokinetic and safety considerations, and outlines the recommendations for use of this class of medication in the HIV-1-infected pregnant woman...
  48. pmc "We don't exist": a qualitative study of marginalization experienced by HIV-positive lesbian, bisexual, queer and transgender women in Toronto, Canada
    Carmen H Logie
    Faculty of Social Work, University of Calgary, Calgary, Alberta, Canada
    J Int AIDS Soc 15:17392. 2012
    ..The study objective was to explore challenges in daily life and experiences of accessing HIV services among HIV-positive LBQT women in Toronto, Canada...
  49. pmc Validation of case-finding algorithms derived from administrative data for identifying adults living with human immunodeficiency virus infection
    Tony Antoniou
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    PLoS ONE 6:e21748. 2011
    ..We sought to validate a case-finding algorithm for human immunodeficiency virus (HIV) infection using administrative health databases in Ontario, Canada...
  50. pmc Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study
    Mark H Yudin
    The Department of Obstetrics and Gynecology, St, Michael s Hospital, Toronto, Ontario, Canada
    Reprod Health 7:7. 2010
    ..abstract:..
  51. doi request reprint HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy
    Constance A M Finney
    Sandra Rotman Centre for Global Health, University Health Network, University of Toronto, Toronto, Ontario, Canada
    AIDS 27:325-35. 2013
    ....
  52. ncbi request reprint An economic evaluation of treatments for HIV-associated facial lipoatrophy: a cost-utility analysis
    Sirianong Peyasantiwong
    Department of Health Policy, Management and Evaluation, Faculty of Medicine, 155 College Street 4th Floor, University of Toronto, Toronto, Ontario M5T 3M6, Canada
    Curr HIV Res 8:386-95. 2010
    ..Information gleaned from an economic evaluation of treatments for FLA could inform policy decision making concerning coverage...
  53. doi request reprint Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study
    Tony Antoniou
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Arch Intern Med 170:1045-9. 2010
    ..The objective of this study was to characterize the risk of hyperkalemia-associated hospitalization in elderly patients who were being treated with trimethoprim-sulfamethoxazole along with either an ACEI or an ARB...
  54. pmc Sustainability of an HIV PEP Program for Sexual Assault Survivors: "Lessons Learned" from Health Care Providers
    Janice Du Mont
    Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
    Open AIDS J 5:102-12. 2011
    ..We discuss the implications of these findings and the actions that were taken to address the challenges...
  55. ncbi request reprint Severe acute respiratory syndrome
    Michael D Christian
    Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
    Clin Infect Dis 38:1420-7. 2004
    ..We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience...
  56. pmc A psycho-educational HIV/STI prevention intervention for internally displaced women in Leogane, Haiti: results from a non-randomized cohort pilot study
    Carmen H Logie
    Factor Inwentash Faculty of Social Work, University of Toronto, Toronto, Canada Women s College Research Institute, University of Toronto, Toronto, Canada
    PLoS ONE 9:e89836. 2014
    ....
  57. ncbi request reprint Salvage antiretroviral therapy in HIV infection
    Mona R Loutfy
    Department of Medicine, Division of Infectious Diseases, University of Toronto, Canada
    Expert Opin Pharmacother 3:81-90. 2002
    ..It is important that new agents and new targets continue to be developed as an increasing number of patients in practice have exhausted all treatment options...
  58. ncbi request reprint Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
    Mona R Loutfy
    North York General Hospital, Toronto General Research Institute, Toronto, Ontario
    JAMA 290:3222-8. 2003
    ..Severe acute respiratory syndrome (SARS) is a new clinical entity for which no effective therapeutic strategy has been developed...